What is this medicine used for?
FDA-approved uses
- Psychotic disorders; selected Tourette and restricted pediatric behavioral indications — Adults; selected children ages 3–12 under specialist care. Indication and age-specific selection, not routine ADHD use.Haloperidol oral tablets.
- Schizophrenia with acute agitation requiring short-acting treatment — Adults. Professional administration; IV route not approved.Haloperidol lactate short-acting intramuscular injection.
- Schizophrenia maintenance after oral stabilization — Adults. Every-four-week depot with initial-dose limits.Haloperidol decanoate long-acting intramuscular injection.
What should I expect?
The goal is to reduce the symptoms for which the selected product is prescribed. Sedation can be noticeable early; it is not by itself evidence that psychosisPsychosisPsychosis describes symptoms that affect a person’s ability to tell what is real. These can include hallucinations, delusions and disorganized thinking or speech.Psychosis can occur with different mental or physical health conditions, some medicines or substance use. It does not automatically mean schizophrenia. New symptoms need prompt professional assessment. is adequately treated.
Report new restlessness, stiffness or involuntary movements. The long-acting injection is intended for adults already stabilized on oral haloperidol, and dose changes take time to assess.
How do I take it safely?
Follow the exact oral prescription. Short-acting intramuscular and long-acting decanoate injections are different products given by clinicians. Decanoate is for adults stabilized on oral haloperidol; neither covered injection is approved for intravenous administration.
Follow movement symptoms, sedation, blood pressure and falls. The decanoate label calls for heart-rhythm and electrolyte assessment before treatment and as needed afterward. Low-white-cell history, fever or infection may require blood counts. Check interactions, particularly other heart-rhythm medicines, sedatives and lithium; avoid alcohol.
Parkinson disease, dementia with Lewy bodies and certain states of severe brain or nervous-system depression are reasons haloperidol may be unsuitable or contraindicated. Discuss pregnancy and breastfeeding; newborn movement or withdrawal effects can follow late-pregnancy exposure. Pediatric oral uses have strict age and condition limits.
Arrange stopping and relapse monitoring with the prescriber. Do not double a missed oral dose; contact the clinic about a missed depot appointment.
Liver disease, seizure history and older age require additional caution.
Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.
What side effects should I know about?
- Restlessness, stiffness, sedation, dizziness and prolactin-related effects.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)HALOPERIDOL - haloperidol tablet
- View FDA Prescribing Information (PDF) (opens in a new tab)HALOPERIDOL- haloperidol lactate injection, solution
- View FDA Prescribing Information (PDF) (opens in a new tab)Haldol Decanoate intramuscular injection
Which warning signs need help?
- The boxed warningFDA boxed warningAn FDA boxed warning is a prominently displayed warning in US prescribing information about especially serious risks, which may include death or serious injury. It is sometimes called a black-box warning.It highlights information that needs particular attention when deciding whether and how to use a medicine. A boxed warning does not mean the medicine is banned or that everyone will experience the harm. Read the medicine-specific warning and discuss it with your prescriber. concerns increased death in older adults with dementia-related psychosisPsychosisPsychosis describes symptoms that affect a person’s ability to tell what is real. These can include hallucinations, delusions and disorganized thinking or speech.Psychosis can occur with different mental or physical health conditions, some medicines or substance use. It does not automatically mean schizophrenia. New symptoms need prompt professional assessment.; the covered products are not approved for that use.
- High fever, rigid muscles and confusion can be neuroleptic malignant syndrome. Fainting or an irregular heartbeat can signal a dangerous rhythm problem. Seek emergency care for these symptoms or severe neck/throat spasms that affect breathing or swallowing. Seek emergency care for a seizure, collapse, serious breathing difficulty, facial or throat swelling, or suspected overdose.
- Report new involuntary movements, severe restlessness, fever or infection promptly. Tardive dyskinesiaTardive dyskinesiaTardive dyskinesia is a movement disorder that can develop after exposure to certain medicines, particularly antipsychotics. It causes repeated movements that the person does not intend, such as lip-smacking, chewing motions or tongue movements; other body areas can be affected.The movements may persist after the medicine is stopped. Report new involuntary movements to your prescriber; medication changes should be planned with them. can persist after stopping. Low blood pressure, seizures and a serious brain reaction when combined with lithium also require attention.
What else should I know to stay safe?
- Do not use with Parkinson disease, coma or severe nervous-system depression, or product allergy; injection labels also exclude dementia with Lewy bodies. Liver disease, seizure history and older age require extra caution.
- Review other heart-rhythm medicines, sedatives and lithium; avoid alcohol. Monitor movement symptoms, falls and blood pressure. Decanoate treatment requires heart-rhythm and electrolyte assessment before treatment and as needed; blood counts may be needed with relevant history or symptoms.
- Covered injections are not approved for intravenous use, and decanoate requires prior oral stabilization. Treatment interruptions or stopping need a clinician-led plan. Discuss pregnancy and breastfeeding because late-pregnancy exposure can affect the newborn.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- Restlessness can be a medication effect. Tell the prescriber about a new inability to sit still instead of assuming the illness is getting worse.
- Short-acting and decanoate injections have different purposes and instructions. A familiar drug name does not make their doses or routes interchangeable.
How does it work?
Haloperidol changes how brain cells respond to dopamine, a chemical messenger involved in several brain functions. Its main known action is to block dopamine D2 receptors, proteins that receive that particular signal. This is thought to contribute to treatment benefit, although the complete mechanism is not established.
How was this medicine developed?
Haloperidol is an older antipsychotic with several delivery forms. The FDA approved the reviewed long-acting decanoate application in 1986; that date refers to the depot product, rather than the first use of haloperidol.
How do I say the name?
Haloperidol: ha-loe-PER-i-dole. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
Oral tablets
Individualized daily dosing.
Short-acting IM lactate
Professional acute treatment; not approved IV.
Long-acting IM decanoate
After oral stabilization; first injection no more than 100 mg.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Haloperidol tablets: prescribing information — mechanism explanation
Scope: Mechanism explanation only. Source sections checked: Clinical Pharmacology..
- Haloperidol: FDA approval history
- Haloperidol: patient medicine information
- Haloperidol lactate injection prescribing information
- Haldol Decanoate (haloperidol decanoate): prescribing information — mechanism explanation
Scope: Mechanism explanation only. Source sections checked: 5.14 Hyperprolactinemia; 12.1 Mechanism of Action; 12.2 Pharmacodynamics; 12.3 Pharmacokinetics..
- Haldol Decanoate intramuscular injection: official prescribing information (PDF)
- Haloperidol: Package Insert / Prescribing Information / MOA
- DailyMed - HALOPERIDOL DECANOATE injection
- Risperidone: prescribing information
- Haloperidol: verified neutral parent, PubChem CID 3559
- NIMH: Understanding psychosis
- Frequently Asked Questions about Labeling for Prescription Medicines | FDA
- Tardive dyskinesia: MedlinePlus Medical Encyclopedia
- NIMH: Mental Health Medications
Giving medicine safely to children: family guide (PDF, 3 pages)

